BAYN.DE, XETRA

Bayer Aktiengesellschaft (BAYN.DE)

Price (as of October 21)

49.8EUR

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

DERM

Journey Medical Corporation

-0.08

EMBC

Embecta Corp.

-0.05

DVAX

Dynavax Technologies Corporation

-0.04

HCM

HUTCHMED (China) Limited

-0.04

AERI

Aerie Pharmaceuticals, Inc.

-0.04

HEXO

HEXO Corp.

-0.03

AMYT

Amryt Pharma plc

-0.03

ALKS

Alkermes plc

-0.03

AQST

Aquestive Therapeutics, Inc.

-0.03

AZN.L

AstraZeneca PLC

-0.03

Show more

Highest within Industry

Symbol Correlation

AKAN

Akanda Corp.

0.14

AYTU

Aytu BioPharma, Inc.

0.11

ELAN

Elanco Animal Health Incorporated

0.08

CPIX

Cumberland Pharmaceuticals Inc.

0.06

ACRX

AcelRx Pharmaceuticals, Inc.

0.05

ALVO

Alvotech

0.04

PFE

Pfizer Inc.

0.04

BMY

Bristol-Myers Squibb Company

0.03

ZTS

Zoetis Inc.

0.03

JNJ

Johnson & Johnson

0.03

Show more

Profile

Sector:
Healthcare
Industry:
Drug Manufacturers

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.